1080 Antibody Persistence 5 Years After Vaccination at 2 to 10 Years of Age With Quadrivalent MenACWY-CRM Conjugate Vaccine, And Responses To a Booster Vaccination

Gelijkaardige items

• Persistence of the immune response after MenACWY-CRM vaccination and response to a booster dose, in adolescents, children and infants
  door: Baxter, Roger, et al.
  Gepubliceerd in: (2016)
• 1085 Persistence of Meningococcal Bactericidal Antibodies and Booster Response at 60-Months of Age in Children Who Received Infant Or Toddler Doses of MenACWY-CRM Conjugate Vaccine
  door: Klein, Nicola P., et al.
  Gepubliceerd in: (2014)
• 2456. Immunogenicity and Safety of a MenACWY-CRM Booster Dose 4–6 Years After Primary Quadrivalent Meningococcal Conjugate Vaccination in Healthy US Adolescents and Adults
  door: Tipton, Mary, et al.
  Gepubliceerd in: (2018)
• Quadrivalent Meningococcal Vaccination of Adults: Phase III Comparison of an Investigational Conjugate Vaccine, MenACWY-CRM, with the Licensed Vaccine, Menactra
  door: Reisinger, Keith S., et al.
  Gepubliceerd in: (2009)
• Bactericidal antibodies against hypervirulent Neisseria meningitidis C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in children
  door: Giuliani, Marzia Monica, et al.
  Gepubliceerd in: (2020)